Schedule 13G ownership disclosure
Vallon Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 92023M101
Event date: 2022-09-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 849,489
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-22-003232
- Form type
- SC 13G
- Filer
- Markey John
- CIK
- CIK 1948530
- Filed
- Sep 29, 2022
- Reporting period
- Sep 28, 2022
- Description
- Schedule 13G beneficial ownership